Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5622983 | 0.84 | FDPS (0.31) | — | |
| SCHEMBL25408854 | 0.83 | DNM1 (0.32) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL9629122 | 0.82 | — | — | |
| SCHEMBL7597797 | 0.81 | TSHR (0.38) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL7597230 | 0.81 | TSHR (0.38) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL7601029 | 0.81 | TSHR (0.38) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL7593376 | 0.81 | TSHR (0.38) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL7596164 | 0.81 | TSHR (0.38) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL4464194 | 0.74 | — | — | |
| SCHEMBL29027947 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180133664-A1 | Methods for Treating Filled Microporous Membranes | PPG INDUSTRIES OHIO, INC. | 2018-05-17 | — | — | US | claimed |
| US-10888824-B2 | Methods for treating filled microporous membranes | PPG INDUSTRIES OHIO, INC. (US) | 2021-01-12 | — | — | US | disclosed |
| US-10420796-B2 | Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease | SEIKAGAKU CORPORATION (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20180133664-A1 | Methods for Treating Filled Microporous Membranes | PPG INDUSTRIES OHIO, INC. | 2018-05-17 | — | — | US | disclosed |
| EP-2431386-B1 | Na+/Mg2+ exchanger | FBN LEIBNIZ INST FÜR NUTZTIERBIOLOGIE (DE) | 2015-02-25 | — | — | EP | disclosed |
| EP-1996236-A2 | NOVEL BIOCONJUGATES AS THERAPEUTIC AGENT AND SYNTHESIS THEREOF | National Institute of Immunology (IN) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007108013-A2 | NOVEL BIOCONJUGATES AS THERAPEUTIC AGENT AND SYNTHESIS THEREOF | NATIONAL INSTITUTE OF IMMUNOLOGY (IN) | 2007-09-27 | — | — | WO | disclosed |
| EP-1784496-A1 | BIOCHEMICAL SYNTHESIS OF 1,4-BUTANEDIAMINE | DSMIP Assets B.V. (NL) | 2007-05-16 | — | — | EP | disclosed |
| WO-2006005603-A1 | BIOCHEMICAL SYNTHESIS OF 1,4-BUTANEDIAMINE | DSM IP ASSETS B.V. (NL) | 2006-01-19 | — | — | WO | disclosed |